248
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Avascular Necrosis of Bone in Patients with Uveitis Treated with Systemic Corticosteroids

, MBChB, FRCOphth, , MBChB (Hons), FRCOphth & , BSc ,MBChB, DO, FRCP, FRCOphth
Pages 869-875 | Received 18 Feb 2020, Accepted 26 Oct 2020, Published online: 04 Feb 2021

References

  • Smith WM, Larson TA, Meleth AD, et al. Corticosteroid-associated osteonecrosis: a rare, but serious, complication in uveitis. Ocul Immunol Inflamm. 2013;21(2):102–107. doi:10.3109/09273948.2012.740129.
  • Jones NP, Anderton LC, Cheong FM, et al. Corticosteroid-induced osteoporosis in patients with uveitis. Eye. 2002;16(5):587–593. doi:10.1038/sj.eye.6700163.
  • Shah KN, Racine J, Jones LC, et al. Pathophysiology and risk factors for osteonecrosis. Curr Rev Musculoskelet Med. 2015;8:201–209.
  • Yoon BH, Mont MA, Koo KH, et al. The 2019 revised version of association research circulation osseous staging system of osteonecrosis of the femoral head. J Arthroplasty. 2020;35(4):933–940. doi:10.1016/j.arth.2019.11.029.
  • Gladman DD, Chaudhry-Ahluwalia V, Ibañez D, et al. Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus. J Rheumatol. 2001;28:2226–2229.
  • Hussein S, Suitner M, Béland-Bonenfant S, et al. Monitoring of osteonecrosis in systemic lupus erythematosus: A systematic review and metaanalysis. J Rheumatol. 2018;45(10):1462–1476. doi:10.3899/jrheum.170837.
  • Atas N, Bitik B, Varan O, et al. Clinical characteristics of avascular necrosis in patients with Behçet disease: a case series and literature review. Rheumatol Int. 2019;39:153–159.
  • Schlumpf U, Vonwil T. [Bilateral femur head necrosis following high dosage corticosteroid therapy for chorioretinitis]. Schweiz Med Wochenschr. 1985;115:488–494.
  • Lee SH, Chang SS, Lee M, et al. Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: A systematic review and meta-analysis. Osteoporos Int. 2014;25(3):1131–1139. doi:10.1007/s00198-013-2575-3.
  • Jones NP. Manchester Uveitis Clinic: the first 3000 patients: 1. Epidemiol Casemix Ocul Immunol Inflamm. 2015;23(2):118–126. doi:10.3109/09273948.2013.855799.
  • Jones NP. Manchester Uveitis Clinic: the first 3000 patients: 2. Compl Manag Ocul Immunol Inflamm. 2015;23(2):127–134. doi:10.3109/09273948.2014.968671.
  • Shigemura T, Nakamura J, Kishida S, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology (Oxford). 2011;50:2023–2028.
  • Schachtner T, Otto NM, Reinke P. Cyclosporine use and male gender are independent determinants of avascular necrosis after kidney transplantation: A cohort study. Nephrol Dial Transplant. 2018;33(11):2060–2066. doi:10.1093/ndt/gfy148.
  • Kwon HH, Bang SY, Won S, et al. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus. Lupus. 2018;27(10):1644–1651. doi:10.1177/0961203318784648.
  • Cassoni A, Romeo U, Terenzi V, et al. Adalimumab: another medication related to osteonecrosis of the jaws? Case Rep Dent. 2016. doi:10.1155/2016/2856926.
  • Zhang YZ, Cao XY, Li XC, et al. Accuracy of MRI diagnosis of early osteonecrosis of the femoral head: A meta-analysis and systematic review. J Orthop Surg Res. 2018;13(1):167. doi:10.1186/s13018-018-0836-8.
  • Sun W, Wang B-L, Liu B-L, et al. Osteonecrosis in patients after Severe Acute Respiratory Syndrome (SARS). J Clin Rheumatol. 2010;16(2):61–63. doi:10.1097/RHU.0b013e3181cf3464.
  • Jones LC, Mont MA, Le TB, et al. Procoagulants and osteonecrosis. J Rheumatol. 2003;30:783–791.
  • Johannesdottir SA, Horváth-Puho E, Dekkers OM, et al. Use of glucocorticoids and risk of venous thromboembolism: A nationwide population-based case-control study. JAMA Intern Med. 2013;173(9):743–752. doi:10.1001/jamainternmed.2013.122.
  • Doğan I, Kalyoncu U, Kiliç L, et al. Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid. Turk J Med Sci. 2020;50:219–224.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.